CD83 Regulation of Lymphocyte Development and Function

CD83 对淋巴细胞发育和功能的调节

• 批准号: 7117861
• 负责人: THOMAS F TEDDER
• 金额: $ 27.75万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-20 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7117861
• 关键词: CD antigens; T lymphocyte; athymic mouse; biological signal transduction; cell age; cell differentiation; cell growth regulation; cell surface receptors; dendritic cells; extracellular; gene expression; genetic models; genetically modified animals; helper T lymphocyte; immune response; immunogenetics; in situ hybridization; laboratory mouse; leukocyte activation /transformation; ligands; polymerase chain reaction; protein structure function; receptor binding; receptor expression; thymus

DESCRIPTION (provided by applicant): Lymphocytes are the central mediators of cellular and humoral immunity, but they depend on dendritic and other reticuloendothelial cells during development and for the generation of acquired immunity. Lymphocyte function and interactions with dendritic cells are regulated through cell-surface molecules that mediate intercellular communication, generate transmembrane signals, and direct lymphocyte development and localization within tissues. Aberrant lymphocyte and dendritic cell functions contribute to immunodeficiencies, autoimmune conditions, age-related defects in immunity, and malignancies. The aim of these studies is to examine the function of CD83, a cell-surface receptor that we first identified as a member of the immunoglobulin superfamily predominantly expressed by dendritic cells in humans. Based on the remarkable phenotype of CD83-deficient (CD83-/-) mice that we have generated, CD83 functions as an essential receptor for T lymphocyte selection and/or lineage commitment. Thus, CD83 engagement uniquely represents a new regulatory step for CD4+ T cell development in the thymus, but is likely to have additional functions in the immune system. We propose that CD83 expressed by mouse dendritic and thymic epithelial cells binds extracellular ligand(s), which inform developing and mature lymphocytes of their extracellular microenvironment in vivo. These signals may regulate lymphocyte activation and survival in the periphery and thereby regulate cellular and humoral immune responses. Three specific aims are designed to test this hypothesis and to further our knowledge of how CD83 regulates normal lymphocyte development and function. Specific aim 1 will determine how CD83 regulates thymocyte development in vivo and in vitro. Specific aim 2 will determine whether and how CD83 regulates peripheral lymphocyte survival. In specific aim 3, we will determine whether CD83 binding to extracellular ligand(s) regulates lymphocyte development and function in vivo by identifying and characterizing CD83 ligands expressed by mouse thymocytes. Since CD83 expression provides an important regulatory checkpoint for helper T cell development, understanding its function may provide mechanisms for modulating humoral immunity and for the treatment of immunodeficiency, autoimmunity and malignancies

描述（由申请人提供）：淋巴细胞是细胞和体液免疫的核心介体，但它们依赖于开发过程中的树突状和其他网状内皮细胞，以及产生获得的免疫力。淋巴细胞功能以及与树突状细胞的相互作用通过介导细胞间通信，产生跨膜信号以及直接淋巴细胞发育和组织中的直接淋巴细胞发育和定位的细胞表面分子进行调节。异常的淋巴细胞和树突状细胞功能有助于免疫缺陷，自身免疫性条件，免疫中与年龄相关的缺陷和恶性肿瘤。这些研究的目的是检查CD83的功能，CD83是一种细胞表面受体，我们首先将其鉴定为人类中树突状细胞以树突状细胞为主的免疫球蛋白超家族成员。基于我们已经生成的CD83缺陷（CD83 - / - ）小鼠的显着表型，CD83是T淋巴细胞选择和/或谱系承诺的必不可少的受体。因此，CD83参与唯一代表了胸腺中CD4+ T细胞发育的新调节步骤，但可能在免疫系统中具有其他功能。我们提出，小鼠树突状和胸腺上皮细胞表达的CD83结合了细胞外配体，这些配体在体内为其细胞外微环境的发育和成熟淋巴细胞提供了信息。这些信号可能调节周围的淋巴细胞激活和存活率，从而调节细胞和体液免疫反应。设计三个特定目标旨在检验这一假设，并进一步了解CD83如何调节正常淋巴细胞发育和功能。具体目标1将决定CD83如何调节体内和体外胸腺细胞发育。具体目标2将确定CD83是否以及如何调节外周淋巴细胞存活率。在特定的目标3中，我们将通过识别和表征由小鼠胸腺细胞表达的CD83配体来确定CD83与细胞外配体的结合是否可以调节体内淋巴细胞的发育和功能。由于CD83表达式为辅助T细胞的开发提供了重要的调节检查点，因此了解其功能可能提供调节体液免疫力和治疗免疫缺陷，自身免疫和恶性肿瘤的机制